NCT01654185View on ClinicalTrials.gov

Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2016

Conditions
Metastatic Breast Cancer
Interventions
DRUG

AI plus Dimethyldiguanide

AI 1 tablet per day Dimethyldiguanide 0.5 bid

DRUG

Aromatase Inhibitor

1 tablet per day

Trial Locations (1)

200032

Fudan University Cancer Hospital, Shanghai

All Listed Sponsors
lead

Xichun Hu

OTHER

NCT01654185 - Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter